IEEE 5G Summit: Commercializing 5G mm-WAVE Arrays: Technical and Economic Factors

Tuesday, 4 June 2019
BCEC, Room 160ABC
15:50 - 16:25

Polls and Questions: Participate in polls and ask questions using Slido

Speaker:  ​​​​​​Alastair Upton and Nitin Jain, Anokiwave

5G has arrived.  One consequence will be the largest volume of millimeter-wave (mmW) ICs ever produced! A radical use case evolution is happening to make ubiquitous 5G possible by harnessing mmW spectrum to increase data speeds by orders of magnitude. We are now beginning the multi-year rollout of 5G NR that should take us to through the next decade.   Anokiwave continues to deliver the technology needed for mmW 5G telecommunication networks with second generation of 5G ICs supporting 3GPP compliance for 5G-NR now available, and our platform of 3rd generation solutions in advanced development. For this market to realize its huge potential, and to develop as promised, OEMs, and RF component suppliers like Anokiwave need to not only address the technical challenges, but also consider the economic factors that will ensure the success of 5G. One example of where these technical and economic factors overlap is at the active antenna air interface, where the link budget determining the user experience and Quality-of-Service is largely determined. Here, the most important factors determining the performance of active antennas – and consequently the radio link – are the observable sensitivity and radiated power. While transmitting enough signal power is critical, it is also essential that it must be developed efficiently. Excessive power dissipation not only results in economic consequences from the obvious increase in operating costs, but also to larger size and weight, reduced reliability, and more restrictions in unit deployment, all resulting in increases in the total cost of ownership. This presentation will discuss these as well as other technical and economic factors related to commercializing 5G mmWave arrays, and what the industry is doing to solve them.